Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 185 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Marstacimab for the treatment of haemophilia A and haemophilia B	Marstacimab (PF-06741086)	Haemophilia A , Haemophilia B	Haematology	2023	View \| Download
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders	Mexiletine hydrochloride (Namuscla)	Myotonia	Genetic Disorders	2023	View \| Download
Mim8 for prophylaxis of haemophilia A	NNC0365-3769	Haemophilia A	Haematology	2023	View \| Download
Mirvetuximab soravtansine for advanced, epithelial ovarian, fallopian tube, or primary peritoneal cancer with high folate receptor-alpha expression	Mirvetuximab soravtansine (IMGN853)	Epithelial ovarian cancer , Fallopian tube cancer , primary peritoneal cancer	Female Reproductive Cancer	2023	View \| Download
Neoadjuvant nivolumab with gemcitabine and cisplatin followed by adjuvant nivolumab for previously-untreated muscle-invasive bladder cancer	Cisplatin (Platinol) , Gemcitabine (Gemzar; gemcitabine hydrochloride) , Nivolumab (Opdivo; BMS-936558; ONO-4538)	Bladder cancer	Urological Cancer	2023	View \| Download
Nipocalimab for Generalised Myasthenia Gravis	Nipocalimab	Myasthenia gravis (MG)	Musculoskeletal System	2023	View \| Download
Niraparib as maintenance therapy for treating recurrent or primary-advanced endometrial cancer after chemotherapy in combination with dostarlimab.	Chemotherapy , Dostarlimab (TSR-042; Jemperli) , Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate)	Endometrial cancer	Female Reproductive Cancer	2023	View \| Download
Niraparib with pembrolizumab maintenance therapy for metastatic stage III or IV non-small cell lung cancer	Niraparib (Zejula; MK 4827; JNJ 64091742; GSK 3985771; niraparib tosylate monohydrate) , Pembrolizumab (Keytruda; MK-3475)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Nivolumab adjuvant therapy for renal cell carcinoma	Nivolumab (Opdivo; BMS-936558; ONO-4538)	Renal cell carcinoma (RCC)	Renal Cancer	2023	View \| Download
NVK-002 for myopia in children	NVK-002	Myopia	Ophthalmology	2023	View \| Download